These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5332009)

  • 1. [On the use of Persantin forte in patients with coronary disease in a controlled clinical test].
    Messerich J
    Med Welt; 1966 Sep; (36):1904-6. PubMed ID: 5332009
    [No Abstract]   [Full Text] [Related]  

  • 2. Dipyridamole in coronary heart disease.
    Savola J
    Practitioner; 1982 Apr; 226(1366):779-80. PubMed ID: 7045852
    [No Abstract]   [Full Text] [Related]  

  • 3. [Application of persantin in coronary disease].
    Markiewicz M; Bielak Z
    Pol Tyg Lek; 1966 Apr; 21(15):552-3. PubMed ID: 5939764
    [No Abstract]   [Full Text] [Related]  

  • 4. [The antithrombotic action of oral anticoagulants, acetylsalicylic acid (Aspirin) and dipyridamole (Persantin)].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1984 Oct; 128(43):2047-9. PubMed ID: 6390223
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical aspects of persantin, segontin and trimanyl in the light of the results of experimental studies on the coronary circulation in dogs].
    Janicki K; Wcislo W
    Pol Tyg Lek; 1967 May; 22(21):779-81. PubMed ID: 6040998
    [No Abstract]   [Full Text] [Related]  

  • 6. Persantin.
    Med Lett Drugs Ther; 1966 Apr; 8(7):27-8. PubMed ID: 4956154
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of persantin on myocardial ischemia during open heart surgery].
    Bross W; Aroński A; Bross T; Olejak B
    Kardiol Pol; 1966; 9(2):111-3. PubMed ID: 5911932
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental studies on the survival period following gradual narrowing of the left coronary artery in Persantin pretreated swine].
    Wernitsch W; Richter G; Halmagyi M; Zeitler E
    Thoraxchir Vask Chir; 1967 Aug; 15(4):429-35. PubMed ID: 5244168
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and experimental observations on coronary-active substances].
    Moser K
    Wien Z Inn Med; 1965 Oct; 46(10):393-400. PubMed ID: 5326527
    [No Abstract]   [Full Text] [Related]  

  • 10. [Persantin: coronary insufficiency, prevention of thrombosis, kidney failure, intrauterine asphyxia].
    Heynen U
    Z Allgemeinmed; 1972 Feb; 48(5):246-50. PubMed ID: 5063268
    [No Abstract]   [Full Text] [Related]  

  • 11. [Persantin and aspirin in coronary heart disease. The persantin-aspirin reinfarction study group (PARIS)].
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1761-71. PubMed ID: 6779148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-adhesion and anti-coagulant substances in thrombosis therapy. Acetylsalicylic acid and Persantin in the spotlight].
    Stormorken H
    Tidsskr Nor Laegeforen; 1971 Feb; 91(6):449-50. PubMed ID: 5546533
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled clinical trial of "Atromid" (androsterone with ethyl-p-chlorophenoxy-isobutyrate) and "Persantin" (dipyridamole) in cases of myocardial infarction.
    Teik KO; Poh FW; Fun CS; Mong BC
    Med J Malaya; 1966 Mar; 20(3):186-204. PubMed ID: 4223070
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Persantin'-aspirin reinfarction study.
    Douglas AS; Chalmers TC; Klimt CR; Stamler J
    Lancet; 1976 Aug; 2(7983):465-6. PubMed ID: 73757
    [No Abstract]   [Full Text] [Related]  

  • 15. [How important is dipyridamole in patients with ischemic heart disease?].
    Spácil J
    Cas Lek Cesk; 1990 May; 129(18):570-1. PubMed ID: 2350778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of the coronary arteriovenous O2 difference in the man following intravenous injection of dipyridamol (Persantin)].
    Hilger HH; Wagner J; Hellwig H; Louven B; Wackerbauer J; Schaede A
    Z Kreislaufforsch; 1967 Dec; 56(12):1192-206. PubMed ID: 5593119
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical research on the action of dipyridamole administered alone or with benziodarone in coronary insufficiency].
    Rădulescu M
    Med Interna (Bucur); 1965 Oct; 17(10):1225-9. PubMed ID: 5862277
    [No Abstract]   [Full Text] [Related]  

  • 18. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 19. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of persantin on spirographic indices in patients with so-called ABE syndrome].
    Kowalski J; Müller J
    Gruzlica; 1965 Apr; 33(4):295-9. PubMed ID: 5319819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.